Diabetes Care, Vol 20, Issue 8 1315-1318, Copyright © 1997 by American Diabetes Association
Determination of amputation level in ischemic limbs. Reappraisal of the measurement of TcPo2
R Wutschert and H Bounameaux
Department of Internal Medicine, University Hospital of Geneva, Switzerland.
OBJECTIVE: To study the accuracy of the measurement of TcPo2 for the
determination of the optimal level of amputation in patients with end-stage
vascular disease (i.e., the level at which the reamputation rate and the
proportion of too-proximal amputations will be minimized). RESEARCH DESIGN
AND METHODS: We used a Medline literature search of all published studies
of the past 12 years that fulfilled predefined quality criteria, and we
analyzed the data by means of receiver operating characteristic (ROC)
curve. RESULTS: Ten studies could be identified with a total of 615
lower-limb amputations (51% of them being performed in diabetic patients)
and a reamputation rate of 16.4%. The best performances of the TcPo2
measurement were obtained between 10 and 20 mmHg with an accuracy of
approximately 80%. CONCLUSIONS: Preoperative TcPo2 measurement may be of
considerable help to predict stump outcome and level of amputation. Our
study provides objective prognostic values for the range 0-50 mmHg and
suggests that TcP02 should usually be 20 mmHg at the site of amputation,
which will predict healing with 80% accuracy and should, therefore, not be
used as a sole criteron. Despite this aid in making his decision about the
amputation level, the surgeon still has to balance between his goal of
achieving primary wound healing and his hope of preserving the maximal limb
length and has to consider patient preferences.